Literature DB >> 10172367

Characterization of drug-related problems in elderly patients on admission to a medical ward.

B J Courtman1, S B Stallings.   

Abstract

The incidence, types, avoidability and risk factors associated with drug-related problems (DRPs) in geriatric patients on admission to a medical ward of the Toronto Hospital were assessed. The admission note and laboratory data of 150 consecutive admissions were reviewed for the presence of an adverse drug reaction, inappropriate dose, non-compliance, drug interaction, or lack of required medication. The avoidability (avoidable, possibly avoidable, or unavoidable) and contribution to hospitalization (major reason, contributing or non contributing) of each DRP was characterized. On admission, 41% of patients had a DRP identified, of which most were potentially avoidable (96.8%) and involved commonly prescribed drugs. The DRP was the major or contributing reason for admission in 31% of cases. Polypharmacy was a statistically significant risk factor for a DRP, particularly for male patients (p = 0.0010). In this elderly population, DRPs were not statistically correlated to age greater than 65 years, gender, renal function, native language, or duration of hospital stay. The incidence of DRPs and hospitalizations in the elderly can potentially be reduced by improving medication use. Enhanced communication, particularly between hospital and community pharmacists and their patients, may be a key mechanism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 10172367

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN: 0008-4123


  18 in total

1.  Does age increase the risk of adverse drug reactions?

Authors:  Bernard Bégaud; Karin Martin; Annie Fourrier; Françoise Haramburu
Journal:  Br J Clin Pharmacol       Date:  2002-11       Impact factor: 4.335

2.  Therapy related hospital admission in patients on polypharmacy in Singapore: a pilot study.

Authors:  Yvonne Koh; Bte Moideen Kutti Fatimah; Shu Chuen Li
Journal:  Pharm World Sci       Date:  2003-08

3.  Adverse drug reactions in a population of hospitalized very elderly patients.

Authors:  Balamurugan Tangiisuran; J Graham Davies; Juliet E Wright; Chakravarthi Rajkumar
Journal:  Drugs Aging       Date:  2012-08-01       Impact factor: 3.923

Review 4.  Polypharmacy in older adults with cancer.

Authors:  Ronald J Maggiore; Cary P Gross; Arti Hurria
Journal:  Oncologist       Date:  2010-04-24

5.  Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause.

Authors:  Maria Cristina G Passarelli; Wilson Jacob-Filho; Albert Figueras
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 6.  Which drugs cause preventable admissions to hospital? A systematic review.

Authors:  R L Howard; A J Avery; S Slavenburg; S Royal; G Pipe; P Lucassen; M Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2006-06-26       Impact factor: 4.335

7.  The relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysis.

Authors:  Anne J Leendertse; Djurre Visser; Antoine C G Egberts; Patricia M L A van den Bemt
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

Review 8.  Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis.

Authors:  T J Oscanoa; F Lizaraso; Alfonso Carvajal
Journal:  Eur J Clin Pharmacol       Date:  2017-03-01       Impact factor: 2.953

Review 9.  Methods for assessing the preventability of adverse drug events: a systematic review.

Authors:  Katja Marja Hakkarainen; Karolina Andersson Sundell; Max Petzold; Staffan Hägg
Journal:  Drug Saf       Date:  2012-02-01       Impact factor: 5.606

10.  Negative clinical outcomes of medication resulting in emergency department visits.

Authors:  María Isabel Baena; Paloma C Fajardo; Antonio Pintor-Mármol; M José Faus; Rosario Marín; Antonio Zarzuelo; José Martínez-Olmos; Fernando Martínez-Martínez
Journal:  Eur J Clin Pharmacol       Date:  2013-10-03       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.